Absolutely, about a month ahead of the rest of Europe in approving and implementing vaccine rollout utilising the effective and vastly cheaper Astro-Zeneca vaccine, and more expensive alternatives where clinically indicated. Despite adverse National factors such as ethnic make-up, population density, multi centre seeding etc our NHS was not overwhelmed unlike Italy, and Spain amongst others and over the pandemic as a whole we are in the middle ground compared to other European countries in per capita mortality and were able to open up economically much earlier. Professor David Spiegelhalter, who I saw at the Hay Festival, acknowledged this as being a UK success story.
Jerry